Henry Schein | HSIC - Sales Revenues

Stock Price
77.00
Daily Change
1.74 2.31%
Monthly
-1.97%
Yearly
-3.57%
Q1 Forecast
73.16

Henry Schein reported $3.34B in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Agilent USD 1.86B 123M Sep/2025
Align Technology USD 1.05B 54.3M Dec/2025
Bruker USD 860.5M 63.1M Sep/2025
Cardinal Health USD 65.63B 1.63B Dec/2025
Charles River Laboratories USD 1000M 32.14M Sep/2025
Cigna USD 72.47B 2.77B Dec/2025
Cooper Companies USD 1.07B 4.9M Sep/2025
CVS Health USD 102.9B 3.99B Sep/2025
Danaher USD 6.84B 790M Dec/2025
Dentsply International USD 904M 32M Sep/2025
Encompass Health USD 1.54B 60M Dec/2025
Henry Schein USD 3.34B 100M Sep/2025
Idexx Laboratories USD 1.09B 10M Dec/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
Laboratory Of America USD 3.56B 30M Sep/2025
McKesson USD 106.16B 3.01B Dec/2025
Mettler Toledo International USD 1.13B 100M Dec/2025
Owens Minor USD 697.26M 15.36M Sep/2025
Quest Diagnostics USD 2.82B 60M Sep/2025
Revvity USD 772.06M 73.06M Dec/2025
Stryker USD 7.2B 1.14B Dec/2025
Tenet Healthcare USD 5.29B 20M Sep/2025
Thermo Fisher Scientific USD 12.21B 1.09B Dec/2025
Universal Health Services USD 4.5B 220M Sep/2025
Waters USD 800M 29M Sep/2025
Zimmer Biomet Holdings USD 2B 80M Sep/2025
Zoetis USD 2.4B 60M Sep/2025